SERPINE1 Overexpression Promotes Malignant Progression and Poor Prognosis of Gastric Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SERPINE1 Overexpression Promotes Malignant Progression and Poor Prognosis of Gastric Cancer
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2022, Issue -, Pages 1-17
Publisher
Hindawi Limited
Online
2022-01-30
DOI
10.1155/2022/2647825
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas via Large-Scale Analysis
- (2021) Xiaoming Huang et al. Frontiers in Oncology
- SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target
- (2021) Shaokun Wang et al. BMC CANCER
- Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy
- (2019) Marko Jevrić et al. BMC CANCER
- Recent advances in gastric cancer early diagnosis
- (2019) Laura Necula et al. WORLD JOURNAL OF GASTROENTEROLOGY
- ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells
- (2019) Rui Xie et al. Journal of Oncology
- Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling
- (2019) Fidan Seker et al. Cancers
- Plasminogen activator inhibitor-1 in cancer research
- (2018) Sijing Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Staging and surgical approaches in gastric cancer: A systematic review
- (2018) Natalie Coburn et al. CANCER TREATMENT REVIEWS
- PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination
- (2018) Yang Peng et al. CANCER LETTERS
- Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients
- (2017) Owen T.M. Chan et al. Oncotarget
- Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination
- (2017) Erika Nakatsuka et al. Oncotarget
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Validated biomarkers: The key to precision treatment in patients with breast cancer
- (2016) Michael J. Duffy et al. BREAST
- Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
- (2014) Manuel Valiente et al. CELL
- Three Decades of Research on Plasminogen Activator Inhibitor-1: A Multifaceted Serpin
- (2013) Ann Gils et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation
- (2012) J. Huang et al. BLOOD
- Protumorigenic Activity of Plasminogen Activator Inhibitor-1 Through an Antiapoptotic Function
- (2012) Hua Fang et al. JNCI-Journal of the National Cancer Institute
- Regulation of thrombin-induced plasminogen activator inhibitor-1 in 4T1 murine breast cancer cells
- (2011) Troy A. McEachron et al. BLOOD COAGULATION & FIBRINOLYSIS
- Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1
- (2011) Manfred Schmitt et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Plasminogen activator inhibitor-1: The double-edged sword in apoptosis
- (2008) Rashna D. Balsara et al. THROMBOSIS AND HAEMOSTASIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started